The main line of business for Novartis India Ltd. is the wholesale distribution of medicines and medical supplies.
It brings different medications into India from various places across the world.
Financial Results:
- Novartis India Ltd. reported Total Income for Q4FY23 of ₹ 93 Crores up from ₹ 113 Crore year on year, a fall of 18%.
- Total Expenses for Q4FY23 of ₹ 69 Crores up from ₹ 94 Crores year on year, fall of 27%.
- Consolidated Net Profit of ₹ 25 Crores, down from a loss of ₹ 24 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ 10.13, down from ₹ -9.47 in the same quarter of the previous year.